(Updated - October 22, 2015 11:35 AM EDT)The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Trader Talk Trading Halts

Merrimack Pharmaceuticals (MACK) Weakness Creates Buying Opportunity, Mizuho Securities SaysOctober 23, 2015 6:51 AM Merrimack (MACK) Onivyde Labeling Appears as Expected, Says Mizuho SecuritiesOctober 22, 2015 2:14 PM Merrimack Pharma (MACK) to Resume Trading at 1:40 PM EDTOctober 22, 2015 1:32 PM Merrimack Pharma (MACK) Halted, News PendingOctober 22, 2015 11:23 AM PharmaEngine Announces Taiwan FDA Approval of ONIVYDE to Treat Metastatic Pancreatic Cancer (MACK)October 22, 2015 9:08 AM PharmaEngine Announces Taiwan FDA Approval of ONIVYDE (TM) (irinotecan liposome injection) for the Treatment of Metastatic Pancreatic CancerOctober 22, 2015 9:05 AM